What is the excess risk of infertility in women after genital chlamydia infection? A systematic review of the evidence

Sexually Transmitted Infections

Volumn 84, Issue 3, 2008, Pages 171-175

  Wallace, L A ^a   Scoular, A ^b   Hart, G ^b   Reid, M ^c   Wilson, P ^c   Goldberg, D J ^a  

^a HEALTH PROTECTION SCOTLAND   (United Kingdom)

^b MRC SOCIAL AND PUBLIC HEALTH SCIENCES UNIT   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; DATA BASE; FEMALE INFERTILITY; GENITAL TRACT INFECTION; HUMAN; PEER REVIEW; PREGNANCY RATE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; ADOLESCENT; ADULT; FEMALE; MICROBIOLOGY; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK FACTOR;

ADOLESCENT; ADULT; CHLAMYDIA INFECTIONS; FEMALE; HUMANS; INFERTILITY, FEMALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 45549109330     PISSN: 13684973     EISSN: None     Source Type: Journal    
DOI: 10.1136/sti.2007.026047     Document Type: Article

References (23)

1. Fenton KA, Ward H. National chlamydia screening programme in England: making progress. Sex Transm Infect 2004;80:333-4.
2. Scottish Intercollegiate Guidelines Network. Management of genital Chlamydia trachomatis infection. No 42.Edinburgh: SIGN, March 2000.
3. Scottish Programme for Clinical Effectiveness in Reproductive Health. National audit of the management of genital Chlamydia trachomatis infection. April 2003.www.abdn.ac.uk/spcerh/publications (accessed March 2006).
4. Fenton KA, Korovessis C, Johnson AM, et al. Sexual behaviour in Britain: reported sexually transmitted infections and prevalent genital Chlamydia trachomatis infection. Lancet 2001;358:1851-4.
5. Stamm WE. Chlamydia trachomatis infections of the adult. In: Holmes KK, Mardh PA, Sparling PF, et al., eds Sexually transmitted diseases, 3rd edn. New York: McGraw Hill, 1999:407-22.
6. Cates WJR, Wasserheit JN. Genital chlamydial infections: epidemiology and reproductive seguelae. Am J Obstet Gynecol 1991;164:1771-81.
7. Carder C, Mercey D, Benn P. Chlamydia trachomatis. Sex Transm Infect 2007;82(Suppl IV):iv10-12.
8. Duncan B, Hart G, Scoular A, et al. Qualitative analysis of psychosocial impact of diagnosis of Chlamydia trachomatis: implications for screening. BMJ 2001;322:195-9.
9. Levine M, Walter S, Lee H, et al. Users' guides to the medical literature IV. How to use an article about harm. JAMA 1994;271:1615-19.
10. Clark KL, Howell MR, Li Y, et al. Hospitalization rates in female US army recruits associated with a screening program for Chlamydia trachomatis. Sex Transm Dis 2002;29:1-5.
11. Katz BP, Thom S, Blythe MJ, et al. Fertility in adolescent women previously treated for genitourinary chlamydial infection. Adolesc Pediatr Gynecol 1994;7:147-52.
12. Department of Health. Second Report of the UK National Screening Committee. London: The Stationery Office, 2000.
13. Low N, Egger M. What should we do about screening for genital chlamydia? Int J Epidemiol 2002;31:891-3.
14. Honey E, Templeton A. Prevention of pelvic inflammatory disease by the control of C trachomatis infection. Int J Gynaecol Obstet 2002;78:257-61.
15. Hu D, Hook EW III, Goldie SJ. The impact of natural history parameters on the cost-effectiveness of Chlamydia trachomatis screening strategies. Sex Transm Dis 2006;33:428-36.
16. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med 1996;334:1362-6.
17. Ostergaard L, Andersen B, Moller JK, et al. Home sampling versus conventional swab sampling for screening of Chlamydia trachomatis in women: a cluster-randomized 1-year follow-up study. Clin Infect Dis 2000;31:951-7.
18. Morre SA, van den Brul AJ, Rozendaal L, et al. The natural course of asymptomatic Chlamydia trachomatis infections: 45% clearance and no development of clinical PID after one year follow-up. Int J STD AIDS 2002;13(Suppl 2):12-18.
19. van Valkengoed IGM, Morre SA, van den Brule AJC, et al. Overestimation of complication rates in evaluations of Chlamydia trachomatis screening programmes - implications for cost-effectiveness analyses. Int J Epidemiol 2004;33:416-25.
20. Low N, Egger M, Sterne JAC, et al. Incidence of severe reproductive tract complications associated with diagnosed genital chlamydial infection: the Uppsala Women's Cohort Study. Sex Transm Infect 2006;82:212-18.
21. Last JM. A dictionary of epidemiology, 3rd ed. New York, USA: Oxford University Press, 1995:32.
22. Senok A, Wilson P, Reid M, et al. Can we evaluate population screening strategies in UK general practice? A pilot randomised controlled trial comparing postal and opportunistic screening for genital chlamydial infection. J Epidemiol Community Health 2005;59:198- 204.
23. Low N. Current status of chlamydia screening in Europe. Eurosurveillance Weekly 2004;10:041007. www.eurosurveillance.org/ ew/2004/041007.asp#5 (accessed December 2006).